Cancer Mortality Declines in Argentina: New Report & Prevention Efforts
- Cancer remains the leading cause of disease-related death among individuals aged 5 to 59, but recent data from Argentina indicates a promising trend: decreasing mortality rates for several...
- The BEN report, systematized through the Cancer Surveillance and Reporting System (SIVER-Ca) of the National Cancer Directorate within Argentina’s Ministry of Health, reveals that mortality from the most...
- Specifically, the report highlights an average annual decrease of 2.3% in cancer mortality among men and 1.3% among women.
Cancer remains the leading cause of disease-related death among individuals aged 5 to 59, but recent data from Argentina indicates a promising trend: decreasing mortality rates for several common cancers. This improvement is largely attributed to advancements in timely diagnosis and increased access to treatment, according to a report from the National Epidemiological Bulletin (BEN).
The BEN report, systematized through the Cancer Surveillance and Reporting System (SIVER-Ca) of the National Cancer Directorate within Argentina’s Ministry of Health, reveals that mortality from the most frequently diagnosed tumors has been declining for over a decade. This positive shift is particularly noticeable in both men and women.
Specifically, the report highlights an average annual decrease of 2.3% in cancer mortality among men and 1.3% among women. This favorable evolution is most pronounced in cancers with high prevalence rates: prostate, colon-rectum, and lung cancer in men, and breast, colon-rectum, and cervical cancer in women.
Colorectal Cancer: A Consistent Decline
Analysis of specific cancer types demonstrates a consistent downward trend in colorectal cancer mortality. With an estimated incidence of 30.5 new cases per 100,000 men and 19.4 per 100,000 women, mortality rates are decreasing by an average of 1.5% annually in both sexes. This suggests that screening programs and improved treatment protocols are having a tangible impact on patient outcomes.
Breast and Prostate Cancer: Positive Trends
Breast cancer, with an estimated incidence of 71.3 new cases per 100,000 women, is also showing encouraging signs. Mortality rates have decreased by an average of 1.7% annually over the past decade, resulting in a rate of 15.4 deaths per 100,000 women in . Similarly, prostate cancer, affecting 44.7 new cases per 100,000 men, exhibits a declining mortality rate, currently at 9.2 deaths per 100,000 inhabitants in .
Cervical Cancer: Stability in Recent Years
While the overall trend is positive, cervical cancer mortality has remained relatively stable over the last decade. The estimated incidence is 16.8 new cases per 100,000 women, with a mortality rate of 8.2 deaths per 100,000 women. This suggests that continued efforts are needed to improve screening and vaccination rates to further reduce the burden of this disease.
Argentina’s Cancer Incidence and Mortality
These trends are particularly noteworthy considering estimates from the International Agency for Research on Cancer (IARC), which indicate that Argentina has a moderately high incidence and mortality rate for cancer overall. The observed declines, represent significant progress in cancer control.
Strengthening Cancer Surveillance and Treatment
In , the Ministry of Health of the Nation implemented a series of initiatives aimed at strengthening coordination with regional jurisdictions to enhance surveillance, diagnosis, and timely treatment. These efforts also focus on training healthcare professionals to improve the quality of care provided to cancer patients.
Key components of this strategy include the implementation of the Screening Information System (SITAM), the Institutional Tumor Registry of Argentina (RITA), the Argentine Hospital Oncopediatric Registry (ROHA), and the Hereditary Tumor Information System (SITHER). These systems are designed to improve data quality, monitor treatment outcomes, and inform healthcare decision-making.
Investing in Research and Palliative Care
Beyond surveillance and treatment, the national health portfolio is actively engaged in generating scientific evidence to support cancer prevention and control strategies. This includes promoting research, training healthcare professionals, developing palliative care teams, and establishing genetic counseling units within oncology departments. Efforts are underway to improve access to diagnostic and treatment services for individuals with high-grade lesions.
The decreasing mortality rates observed in Argentina underscore the importance of early detection, timely diagnosis, and access to effective treatment in the fight against cancer. Continued investment in surveillance systems, research, and healthcare infrastructure will be crucial to sustaining this positive momentum and further reducing the burden of this disease.